LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4386 | 5079 | 0.8633 | 0.8547 |
MDA-MB-231 | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4516 | 5079 | 0.8889 | 0.8828 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4311 | 5079 | 0.8488 | 0.8389 |
MDA-MB-231 | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 3466 | 5079 | 0.6825 | 0.6446 |
MDA-MB-231 | TGX221 | 10 | uM | LJP5 | 72 | hr | 1311 | 4596 | 5079 | 0.9049 | 0.9002 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1311 | 5134 | 5079 | 1.0107 | 1.0107 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1311 | 5133 | 4935 | 1.0403 | 1.0415 |
MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4965 | 5079 | 0.9772 | 0.9762 |
MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4874 | 4935 | 0.9877 | 0.9868 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4830 | 5079 | 0.9511 | 0.9493 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4887 | 4935 | 0.9902 | 0.9896 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 3604 | 5079 | 0.7095 | 0.6777 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3998 | 4935 | 0.8104 | 0.7909 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1914 | 5079 | 0.3771 | 0.2126 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 3119 | 4935 | 0.6322 | 0.5728 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1311 | 2194 | 5079 | 0.4316 | 0.2947 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1311 | 2064 | 4935 | 0.4185 | 0.2672 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1311 | 5226 | 5079 | 1.0291 | 1.0294 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4947 | 5079 | 0.9743 | 0.9732 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4983 | 5079 | 0.9814 | 0.9805 |
MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 5043 | 5079 | 0.9930 | 0.9926 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 5080 | 5079 | 1.0005 | 1.0000 |
MDA-MB-231 | Brivanib | 10 | uM | LJP5 | 72 | hr | 1311 | 4025 | 5079 | 0.7927 | 0.7757 |
MDA-MB-231 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1311 | 4664 | 4935 | 0.9452 | 0.9418 |
MDA-MB-231 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4267 | 4935 | 0.8646 | 0.8532 |